Skip to main content

Table 4 The hematological parameters of TH-treated groups compared to controls

From: The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: an experimental animal study

  Groups  
  0
Normal control
1
-ve control
2
(0.2 g/kg TH)
3
(1.0 g/kg TH)
4
(2.0 g/kg TH)
p valuea
RBC (1012/L) 7.15 (0.27) 6.35 (0.75) 7.35 (1.22) 7.4 (1.025) 6.85 (1.67) 0.088
Hb (g/dl) 15.35 (0.62) 14.1 (1.62) 14.8 (1.92) 15 (1.97) 15.25 (2.77) 0.062
PCV (%) 48 (2.5) 42 (3.25) 48.5 (5) 48.5 (9) 47.5 (8.75) 0.047
MCV (fl) 65.5 (1.5) 66 (4.75) 65.5 (6.75) 66 (1.75) 65.5 (3.75) 0.004
MCH (pg) 21 (2) 21.5 (1.5) 20.5 (2.25) 21 (2.25) 21.5 (2) 0.958
MCHC (g/L) 32.5 (1) 31.5 (1.75) 31 (1.5) 31 (2.5) 32 (3) 0.000
RDW (%) 11.85 (1.7) 13.85 (1.7) 12.25 (2.725) 12.6 (1.5) 12.9 (2.22) 0.010
TWBC (109/L) 4.85 (1.75) 6.14 (8.72) 5.05 (2.4) 4.95 (6) 6.25 (5.7) 0.178
Polymorphs (%) 33 (9.5) 42 (19.75) 34 (16.5) 32 (12) 32.5 (13.5) 0.009
Lymphocytes (%) 66 (5.5) 54 (20.75) 65 (13.5) 64.5 (13.5) 66.5 (15) 0.010
Monocytes (%) 1.5 (1.5) 1.5 (2.5) 1.25 (1) 1 (0) 1 (2) 0.649
Eosinophils (%) 0 (1.25) 0 (1.25) 0 0 (2) 0.5 (1) 0.534
Basophils (%) 0 0 0 0 0 1.000
Platelets’ (109/L) 809.5 (149) 627.5 (196.75) 734 (197) 758.5 (178) 710 (89.5) 0.042
  1. aKruskal-Wallis test. Data are expressed as median interquartile range (IqR). Values are statistically significant at p ≤ 0.05. Legends: TH = Tualang honey, −ve = Negative (group received tumor induction but no honey treatment)